Implanet Net Income Over Time
| ALIMP Stock | EUR 0.21 0.01 4.55% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Implanet Performance and Implanet Correlation. Implanet |
Cross Equities Net Income Analysis
Compare Implanet SA and related stocks such as Theradiag SA, Novacyt, and Diagnostic Medical Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALTHE | (1.9 M) | (1.7 M) | (3.1 M) | (4.1 M) | (4.6 M) | (6.4 M) | (6.5 M) | (6.2 M) | (6.1 M) | (3.8 M) | (3.9 M) | (3.8 M) | (5 M) | (3.7 M) | (5.8 M) | (5.2 M) | (5.4 M) |
| ALNOV | (571.6 K) | (571.6 K) | (455.2 K) | (831.8 K) | (2.9 M) | (10.3 M) | (4.9 M) | (4.8 M) | (4.3 M) | (3.3 M) | 132.4 M | (9.7 M) | (22.2 M) | (28.3 M) | (41.8 M) | (37.6 M) | (35.7 M) |
| ALDMS | (6.1 M) | (2.3 M) | 258 K | (971 K) | (1.1 M) | (2.7 M) | (1.3 M) | (850 K) | (5.5 M) | (3.2 M) | (5.2 M) | (3.9 M) | (6.8 M) | (4.9 M) | (2.9 M) | (2.6 M) | (2.7 M) |
| ALVIO | (7.7 M) | (14.6 M) | (11.5 M) | (15.3 M) | (7.7 M) | (19.4 M) | (22.7 M) | (59.1 M) | (9.4 M) | (33.7 M) | 1.1 M | (5.9 M) | (19.6 M) | (20.3 M) | (23.9 M) | (21.5 M) | (22.6 M) |
| ALIKO | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.6 M) | (571.3 K) | (2.4 M) | (2.3 M) | (3.2 M) | (2.9 M) | (3.1 M) |
| ALCOX | (18.9 M) | (18.9 M) | (18.9 M) | (18.9 M) | (18.9 M) | (18.9 M) | (18.9 M) | (18.9 M) | (18.9 M) | (18.9 M) | (18.1 M) | (43.8 M) | (31.3 M) | (20.9 M) | (22.4 M) | (20.2 M) | (21.2 M) |
| ALDVI | (2 M) | (2 M) | (2 M) | (2 M) | (2 M) | (3.8 M) | (4 M) | (4.7 M) | (4.6 M) | (14.2 M) | (14.8 M) | (12.4 M) | (11.5 M) | (7 M) | (6.5 M) | (5.8 M) | (6.1 M) |
| ALTHX | (518.7 K) | (518.7 K) | (518.7 K) | (518.7 K) | (518.7 K) | (518.7 K) | (1.6 M) | (2.1 M) | (5.3 M) | (5.6 M) | (4.8 M) | (8.2 M) | (6.6 M) | (6.8 M) | (1.8 M) | (1.6 M) | (1.7 M) |
| ALBLU | (94.7 K) | (176.5 K) | (363.4 K) | (815.8 K) | (1.6 M) | (1.1 K) | (3.3 K) | (3 K) | (2.7 M) | (2.8 M) | (2.7 M) | (3.3 M) | (1.5 M) | (1.6 M) | (1.3 M) | (1.1 M) | (1.2 M) |
| ALGAE | (926 K) | (926 K) | (2.3 M) | (1.8 M) | (4 M) | (5.3 M) | (7.6 M) | (7.3 M) | (8.1 M) | (17.3 M) | (6.9 M) | (6.8 M) | (9.9 M) | (14.1 M) | (12.9 M) | (11.6 M) | (12.2 M) |
Implanet SA and related stocks such as Theradiag SA, Novacyt, and Diagnostic Medical Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Implanet SA financial statement analysis. It represents the amount of money remaining after all of Implanet SA operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Implanet SA | ALIMP |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | Technopole Bordeaux Montesquieu, |
| Exchange | Euronext Paris |
EUR 0.21
Additional Tools for Implanet Stock Analysis
When running Implanet's price analysis, check to measure Implanet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Implanet is operating at the current time. Most of Implanet's value examination focuses on studying past and present price action to predict the probability of Implanet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Implanet's price. Additionally, you may evaluate how the addition of Implanet to your portfolios can decrease your overall portfolio volatility.